Ehab is a Senior Regulatory Group Director at F. Hoffmann-La Roche in Singapore, working with the International Regulatory Group. He has over 20 years of experience in various roles at companies including Biogen, Sanofi, and Shire HGT (now Takeda). A pharmacist by training with an M.Sc. in Drug Delivery and Biomedical Sciences, he currently focuses on setting regulatory strategies for international markets, including areas for acceleration and the use of innovation in the pharmaceutical field.